Frank Mühlenbeck
Private Equity Investor chez EMBL Ventures GmbH
Profil
Frank Mühlenbeck is currently the Managing Director at EMBL Ventures GmbH since 2018.
He previously held positions as Chairman at Sensovation AG, Chairman-Supervisory Board at Curetis GmbH, Independent Director at ConforMIS, Inc., Director at Solstice Biologics LLC, and Director at Barnev, Inc. He also served as Director at Sonetik AG from 2014 to 2015 and later as Director at Sonetik AG.
Additionally, he worked as Principal at Boehringer Ingelheim GmbH and Principal at Mitsubishi Research Institute, Inc. He was a Member-Supervisory Board at Affimed NV and Affimed NV Niederlassung Deutschland.
From 2000 to 2008, he was a Partner at firstVentury Equity GmbH, and from 2008 to 2015, he was a Partner at Calibrium Private Investments GmbH.
He also held the position of Principal at Steinbeis Europa Zentrum.
Dr. Mühlenbeck obtained a doctorate degree from Universität Stuttgart.
Postes actifs de Frank Mühlenbeck
| Sociétés | Poste | Début |
|---|---|---|
EMBL Ventures GmbH
 EMBL Ventures GmbH Investment ManagersFinance EMBL Ventures GmbH (EMBL Ventures) is a venture investment arm of EMBL which was founded in 2001 by Drs. Stefan Herr, Christoph Antz and Jan Adams to provide start-up companies exploiting EMBL research and intellectual property with equity and expertise to build up and expand their business. Headquartered in Heidelberg, EMBL Ventures manages funds on behalf of institutional and private investors, forming a triad with EMBL (European Molecular Biology Laboratory) and EMBLEM (EMBL Enterprise Management Technology Transfer GmbH) to provide exclusive access to unique technology commercialization opportunities from the EMBL. In addition, their investment activities complement and exploit synergies with EMBL and EMBLEM, providing financial and strategic investors with access to an attractive private equity market and an international scientific and research community, respectively. | Private Equity Investor | 08/10/2015 |
Anciens postes connus de Frank Mühlenbeck
| Sociétés | Poste | Fin |
|---|---|---|
| CURETIS N.V. | Directeur/Membre du Conseil | 16/06/2016 |
Barnev, Inc.
 Barnev, Inc. Information Technology ServicesTechnology Services Barnev, Inc. is a healthcare information technology company specializing in the development, manufacturing, and marketing of comprehensive monitoring and information solutions to clinicians and hospitals for labor and delivery. The firm is the first to market with delivery suite/product solutions that improve the clinical management of patients, and improve economic efficiency for its customers. Its first product, the BirthTrack™ Continuous Labor Monitoring System, is the most exciting innovation in labor progression monitoring since the Friedman Labor Curve was introduced over 50 years ago. The BirthTrack System is a revolutionary continuous labor monitoring technology that provides obstetric caregivers invaluable, precise, objective, real-time information about the physical progress of labor. | Directeur/Membre du Conseil | 01/10/2015 |
Affimed NV Niederlassung Deutschland
 Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Directeur/Membre du Conseil | 01/10/2015 |
Calibrium Private Investments GmbH
 Calibrium Private Investments GmbH Investment ManagersFinance Calibrium Private Investments GmbH (formerly Aeris Capital AG) is a venture capital firm with headquarters in Zurich, Switzerland. The firm was founded in 2006. | Private Equity Investor | 01/10/2015 |
Solstice Biologics LLC
 Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 01/10/2015 |
Formation de Frank Mühlenbeck
| Universität Stuttgart | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| CONFORMIS, INC. | Health Technology |
| AFFIMED N.V. | Health Technology |
| MITSUBISHI RESEARCH INSTITUTE, INC. | Commercial Services |
| Entreprise privées | 12 |
|---|---|
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Health Technology |
Solstice Biologics LLC
Solstice Biologics LLC Pharmaceuticals: MajorHealth Technology Solstice Biologics LLC develops nucleic acid therapeutics. It specializes in the development of small, cell-permeable RNAi pro-drugs. The company was founded by Steven Dowdy and Curt W. Bradshaw in 2012 and is headquartered in San Diego, CA. | Health Technology |
EMBL Ventures GmbH
EMBL Ventures GmbH Investment ManagersFinance EMBL Ventures GmbH (EMBL Ventures) is a venture investment arm of EMBL which was founded in 2001 by Drs. Stefan Herr, Christoph Antz and Jan Adams to provide start-up companies exploiting EMBL research and intellectual property with equity and expertise to build up and expand their business. Headquartered in Heidelberg, EMBL Ventures manages funds on behalf of institutional and private investors, forming a triad with EMBL (European Molecular Biology Laboratory) and EMBLEM (EMBL Enterprise Management Technology Transfer GmbH) to provide exclusive access to unique technology commercialization opportunities from the EMBL. In addition, their investment activities complement and exploit synergies with EMBL and EMBLEM, providing financial and strategic investors with access to an attractive private equity market and an international scientific and research community, respectively. | Finance |
Affimed NV Niederlassung Deutschland
Affimed NV Niederlassung Deutschland Pharmaceuticals: MajorHealth Technology Affimed NV Niederlassung Deutschland discovers and develops antibody-based therapeutic drugs. The firm generates and develops a pipeline of antibody product candidates based on proprietary technology platform. It offer therapeutic drugs that target autoimmune diseases and tumor cells. The company was founded in 2000 and is headquartered in Heidelberg, Germany. | Health Technology |
Barnev, Inc.
Barnev, Inc. Information Technology ServicesTechnology Services Barnev, Inc. is a healthcare information technology company specializing in the development, manufacturing, and marketing of comprehensive monitoring and information solutions to clinicians and hospitals for labor and delivery. The firm is the first to market with delivery suite/product solutions that improve the clinical management of patients, and improve economic efficiency for its customers. Its first product, the BirthTrack™ Continuous Labor Monitoring System, is the most exciting innovation in labor progression monitoring since the Friedman Labor Curve was introduced over 50 years ago. The BirthTrack System is a revolutionary continuous labor monitoring technology that provides obstetric caregivers invaluable, precise, objective, real-time information about the physical progress of labor. | Technology Services |
Sensovation AG
 Sensovation AG Electronic Equipment/InstrumentsElectronic Technology Sensovation AG manufactures and supplies scientific imaging instrumentation products. The firm specializes in the development and production of scientific imaging and low light detection solutions, based on charge coupled device and complementary metal oxide semiconductor technologies. It offers automated digital microscopes, microarray analyzers, and scientific cameras for bioimaging, diagnostics, and quality control in clean technology applications. It also engages in partnerships focused on building and supplying commercial production systems and platforms. The company was founded by Stefan Bickert and Paul Hing in 2000 and is headquartered in Radolfzell, Germany. | Electronic Technology |
| firstVentury Equity GmbH | Finance |
Calibrium Private Investments GmbH
Calibrium Private Investments GmbH Investment ManagersFinance Calibrium Private Investments GmbH (formerly Aeris Capital AG) is a venture capital firm with headquarters in Zurich, Switzerland. The firm was founded in 2006. | Finance |
Curetis GmbH
 Curetis GmbH Medical SpecialtiesHealth Technology Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany. | Health Technology |
Sonetik AG
 Sonetik AG Medical SpecialtiesHealth Technology Sonetik AG develops and markets digital hearing aids. The firm specializes in the manufacture and distribution of medical aid devices and devices for individuals with hearing impairment or moderate hearing loss. It focuses on the integration of sound processing technologies, such as adaptive directionality, speech recognition, noise reduction, and feedback cancellation. The company was founded by Christian Stromsted in 2007 and is headquartered in Zurich, Switzerland. | Health Technology |
| Steinbeis Europa Zentrum | |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos in August 2007 and is headquartered in Holzgerlingen, Germany. | Health Services |
